Khosla Ventures Acquisition Co. (Nasdaq: KVSA) is a blank-check company sponsored by Khosla Ventures, the Silicon Valley venture capital firm founded by Vinod Khosla. The company filed an S-1/A amendment with the SEC on March 1, 2021, as part of its IPO registration process, completing its public listing that same month with a focus on technology and healthcare opportunities. Khosla Ventures is known for early-stage investments across clean technology, artificial intelligence, and digital health. KVSA subsequently entered into a definitive business combination agreement with Valo Health, a data-driven drug discovery company, with the merger closing in 2022. For comprehensive filing history, deal timelines, and real-time status data on KVSA and hundreds of other SPACs, sign up for full data on SpacDesk.